CONTROLOC IV 40MG POWDER FOR SOLUTION FOR INJECTION Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

controloc iv 40mg powder for solution for injection

mundipharma pharmaceuticals ltd (0000003104) 13 othellos str, nicosia, 1685, 23661 - pantoprazole sodium sesquihydrate - powder for solution for injection - 40mg - pantoprazole sodium sesquihydrate (8000001653) 45,1mg - pantoprazole

Tecartus Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

tecartus

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - Λέμφωμα, mantle-cell - Αντινεοπλασματικοί παράγοντες - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

AFLUON 0.1% W/V NASAL SPRAY, SOLUTION Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

afluon 0.1% w/v nasal spray, solution

meda pharmaceuticals s.a. (0000010732) 63 agiou dimitriou str., alimos, 17456 - azelastine hydrochloride - nasal spray, solution - 0.1% w/v - azelastine hydrochloride (0079307930) 1mg - azelastine

NEFILIN 6MG/0.4MG MODIFIED-RELEASE TABLET Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

nefilin 6mg/0.4mg modified-release tablet

elpen pharmaceutical co inc (0000009615) 95 marathonos ave, pikermi, attica, 19009 - tamsulosin hydrochloride; solifenacin succinate - modified-release tablet - 6mg/0.4mg - tamsulosin hydrochloride (8000002907) 0,4mg; solifenacin succinate (8000002101) 6mg

ARTEPRO 5MG FILM COATED TABLETS Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

artepro 5mg film coated tablets

sapiens pharmaceuticals ltd (0000008387) ierou lochou 39, kapsalos, lemesos, 3082 - rosuvastatin calcium - film coated tablets - 5mg - rosuvastatin calcium (8000001919) 5,2mg

ARTEPRO 40MG FILM COATED TABLETS Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

artepro 40mg film coated tablets

sapiens pharmaceuticals ltd (0000008387) ierou lochou 39, kapsalos, lemesos, 3082 - rosuvastatin calcium - film coated tablets - 40mg - rosuvastatin calcium (8000001919) 41,6mg

ARTEPRO 10MG FILM COATED TABLETS Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

artepro 10mg film coated tablets

sapiens pharmaceuticals ltd (0000008387) ierou lochou 39, kapsalos, lemesos, 3082 - rosuvastatin calcium - film coated tablets - 10mg - rosuvastatin calcium (8000001919) 10,4mg

ARTEPRO 20MG FILM COATED TABLETS Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

artepro 20mg film coated tablets

sapiens pharmaceuticals ltd (0000008387) ierou lochou 39, kapsalos, lemesos, 3082 - rosuvastatin calcium - film coated tablets - 20mg - rosuvastatin calcium (8000001919) 20,8mg

Iclusig Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

iclusig

incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. Βλ. Ενότητες 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.

Solumarv Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

solumarv

marvel lifesciences ltd - ανθρώπινη ινσουλίνη - Σακχαρώδης διαβήτης - Θεραπεία του διαβήτη.